- Home
- RES vs ETNB Comparison
RES vs ETNB Comparison
Compare RES & ETNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RES
- ETNB
- Stock Information
- Founded
- RES 1984
- ETNB 2018
- Country
- RES United States
- ETNB United States
- Employees
- RES N/A
- ETNB N/A
- Industry
- RES Oilfield Services/Equipment
- ETNB Biotechnology: Pharmaceutical Preparations
- Sector
- RES Energy
- ETNB Health Care
- Exchange
- RES Nasdaq
- ETNB Nasdaq
- Market Cap
- RES 1.1B
- ETNB 1.0B
- IPO Year
- RES N/A
- ETNB 2019
- Fundamental
- Price
- RES $5.03
- ETNB $6.06
- Analyst Decision
- RES Hold
- ETNB Strong Buy
- Analyst Count
- RES 3
- ETNB 10
- Target Price
- RES $5.75
- ETNB $27.56
- AVG Volume (30 Days)
- RES 2.2M
- ETNB 2.5M
- Earning Date
- RES 04-24-2025
- ETNB 05-08-2025
- Dividend Yield
- RES 3.34%
- ETNB N/A
- EPS Growth
- RES N/A
- ETNB N/A
- EPS
- RES 0.43
- ETNB N/A
- Revenue
- RES $1,414,999,000.00
- ETNB N/A
- Revenue This Year
- RES $0.07
- ETNB N/A
- Revenue Next Year
- RES $9.25
- ETNB N/A
- P/E Ratio
- RES $11.83
- ETNB N/A
- Revenue Growth
- RES N/A
- ETNB N/A
- 52 Week Low
- RES $4.10
- ETNB $4.16
- 52 Week High
- RES $8.14
- ETNB $11.84
- Technical
- Relative Strength Index (RSI)
- RES 48.09
- ETNB 42.57
- Support Level
- RES $4.18
- ETNB $5.68
- Resistance Level
- RES $4.96
- ETNB $6.13
- Average True Range (ATR)
- RES 0.34
- ETNB 0.69
- MACD
- RES 0.02
- ETNB 0.03
- Stochastic Oscillator
- RES 56.36
- ETNB 51.62
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).